Should a Patient With a History of Melanoma Be Advised Against the Use of Oral Contraceptives? The Relatives Are Worried
Authors:
- Katz VernKVKatz Vern
- Balderston KeithBKBalderston Keith
- 1 November 2003
- journal article
- case report
- Published by Wiley in SKINmed: Dermatology for the Clinician
- Vol. 2 (6) , 382-383
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A pooled analysis of 10 case–control studies of melanoma and oral contraceptive useBritish Journal of Cancer, 2002
- Focus on Primary Care: From Nevus to Neoplasm: Myths of Melanoma in PregnancyObstetrical & Gynecological Survey, 2002
- 17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 ProductionJournal of Investigative Dermatology, 2001
- Oral contraceptive use and risk of melanoma in premenopausal womenBritish Journal of Cancer, 1999
- Hormonal and reproductive influences and risk of melanoma in womenInternational Journal of Epidemiology, 1998
- Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factorsBritish Journal of Cancer, 1996
- Cutaneous Melanoma in Women III. Reproductive Factors and Oral Contraceptive UseAmerican Journal of Epidemiology, 1995
- Oral contraceptive use and risk of cutaneous malignant melanomaCancer Causes & Control, 1992
- Oral contraceptives and malignant melanomaBritish Journal of Cancer, 1991
- Lack of an Elevated Risk of Malignant Melanoma in Relation to Oral Contraceptive Use2JNCI: Journal of the National Cancer Institute, 1984